A detailed history of Copperwynd Financial, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Copperwynd Financial, LLC holds 10,087 shares of IBRX stock, worth $50,535. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,087
Previous 15,987 36.9%
Holding current value
$50,535
Previous $101,000 63.37%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$3.32 - $6.7 $19,588 - $39,530
-5,900 Reduced 36.9%
10,087 $37,000
Q2 2024

Aug 15, 2024

SELL
$4.82 - $9.15 $28,958 - $54,973
-6,008 Reduced 27.32%
15,987 $101,000
Q1 2024

Apr 30, 2024

BUY
$3.23 - $6.17 $20,332 - $38,840
6,295 Added 40.1%
21,995 $118,000
Q4 2023

Feb 13, 2024

BUY
$1.25 - $5.21 $19,625 - $81,797
15,700 New
15,700 $78,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.01B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Copperwynd Financial, LLC Portfolio

Follow Copperwynd Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.